PBM Capital
Deals on record
1
Common Fundraising Type
Series A
Blue Earth Therapeutics
Radioligand therapies
Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.
Deals on record
Common Fundraising Type
Radioligand therapies
Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.